Explore Opportunities

Discover startup investment opportunities on Crowdigy. Browse companies raising capital through equity crowdfunding and private placements across industries.

Our platform features companies seeking funding through Reg CF, Reg A+, and Reg D offerings. Filter by industry, funding stage, or regulation type to find opportunities that match your investment criteria.

Recently Added

RYSE

RYSE

Innovative Technology

The $158 billion smart home market is booming — but 90% of one category is untouched. RYSE is the only company automating it.

CrowdEcho

Greg Gerik

COO
Team member information

CrowdEcho

Innovative Technology

Company behind CrowdEcho

Osteoboost

Osteoboost

Innovative Technology

Osteoboost is the first and only FDA-cleared prescription wearable device specifically designed to treat osteopenia in postmenopausal women, filling a critical treatment gap for over 50 million Americans with low bone density. Named a TIME Best Invention of 2025, this breakthrough medical device delivers precise, calibrated vibration therapy directly to the spine and hips—the areas most vulnerable to osteoporotic fractures. In a gold-standard 12-month clinical trial at the University of Nebraska Medical Center, Osteoboost demonstrated remarkable results: 85% reduction in spine bone density loss, 83% reduction in bone strength loss, and 55% reduction in hip bone density loss—all with zero serious adverse events. The comfortable belt worn for just 30 minutes daily during normal activities like walking or cooking, uses NASA-inspired technology originally developed for astronauts. Cleared through FDA's De Novo pathway with Breakthrough Device designation, Osteoboost offers a drug-free alternative that patients describe as feeling like a gentle massage. Available by prescription for $995 (special launch price), includes free 1-year access to Wellen exercise program, 30-day money-back guarantee, and 1-year warranty. Currently shipping 8-12 weeks after order with free delivery from partner pharmacy.

Scum & Villainy Cantina: Rendezvous

Scum & Villainy Cantina: Rendezvous

Innovative Technology

Company behind Scum & Villainy Cantina: Rendezvous

Movie: Playbook of Johnny

Movie: Playbook of Johnny

Innovative Technology

Company behind Movie: Playbook of Johnny

EMulate Therapeutics

EMulate Therapeutics

Innovative Technology

EMulate has solved one of medicine's most elusive challenges: delivering therapeutic benefits without physical drugs.

CROWDFUNDING HEALTHCARE THERAPEUTICS
HLTHI

Andres Valenin

CEO
Team member information

HLTHI

Innovative Technology

Company behind HLTHI

NextGen Shield, Inc.

NextGen Shield, Inc.

Innovative Technology

MASK NextGen: AI-Driven Cyber Safety for Kids, One Click at a Time

Remi Therapeutics

Remi Therapeutics

Innovative Technology

Company behind Remi Therapeutics

HEALTHCARE THERAPEUTICS AUTISM
Power Hero

Power Hero

Innovative Technology

Our patented technology transforms standard household outlets into fast 240V charging stations, instantly unlocking the massive apartment-dwelling EV market competitors can't reach. No construction, no permits, no capital expenditure—just plug-and-profit scalability.

EV ELECTRIC VEHICLE GREEN ENERGY ENERGY

Most Funded

David (previously Slingshot USA)

David (previously Slingshot USA)

Innovative Technology

David has extended its project and requalified their previous Reg A+ crowdfunding deal with Dalmore Group. It is a feature-length animated film based on the biblical story of David. The film is under production and is under contract with a computer animation studio in Cape Town, South Africa, for the development and creation of David. David is in the process of story development, animatics, research and development, character design, music development, and pipeline development, and will be released in partnership with Angel Studios. David Michael Brett Johnson, Osment Philip Cunningham, and Sanet Kritzinger founded Slingshot USA in 2021. The current crowdfunding campaign has a maximum target of $37.5 million, to reach the project total of $60.9M. The campaign proceeds will be used for marketing, advertising, production expenses, and miscellaneous expenses.

ATLIS Motor Vehicles

Mark H

MANAGING DIRECTOR
Team member information

ATLIS Motor Vehicles

Innovative Technology

ATLIS Motor Vehicles is a battery tech centered automotive company that specializes in platform chassis for upfitter/delivery service enterprises. We also have our own proprietary, patented battery tech for energy storage markets. With some of the best engineers in the industry, we've developed a patent-pending battery technology that allows vehicles to go up to 500 miles on a short 15 minute charge. We have our own proprietary charging infrastructure as well that brings the quick charge to these vehicles. We also have developed a truck for the consumer and fleet markets.

Seragon Pharmaceuticals

Richard H

CHIEF EXECUTIVE OFFICER
Richard A. H......, PhD, has 20 years of drug discovery experience in the biotech sector and, most recently, cofounded Aragon Pharmaceuticals in 2009. Previously, he was Chief Scientific Officer at Ka...

Seragon Pharmaceuticals

Innovative Technology

Our vision is to put good health back into the hands of the consumer by investing in the optimization of human health ...

Mode Mobile

Mode Mobile

Innovative Technology

Mode Mobile is raising funds through Reg A+ crowdfunding with Dealmaker Securities as the Broker-Dealer. The company is transforming smartphones into EarnPhones with its proprietary EarnOS. Mode Mobile’s EarnPhone comes with built-in earning features through which users can earn up to $1,200 per year by listening to music, playing games, tracking fitness, shopping, reading the news, and more. Dan Noaves and Kiran Panesar founded Mode Mobile in April 2015. The current crowdfunding campaign has a maximum target of $37.5 million. The campaign proceeds will be used for product development, marketing, payroll, and overheads.

FD Stonewater

FD Stonewater

Innovative Technology

The STAR Evergreen Fund will seek to achieve a target net IRR of 11-13%* through diversified mission-critical investments in real estate assets across industrial, government, research and development, and office sectors. FD Stonewater, LLC ("FDS") is a privately-held full-service investment, development, and brokerage company with national capabilities delivering real estate solutions through entrepreneurial and thoughtful leadership. Founded in 2003, the Firm is headquartered in Washington, D.C. with 40 employees. In 2022, FDS launched the STAR Evergreen Fund, L.P. for its flagship strategy investing in mission-critical single-tenant real estate assets in U.S. secondary and tertiary markets seeking to generate stable current yield and unlock long-term value through active management. DIFFERENTIATORS Strong Track Record - 20 years of historic gross returns* of 35.3% and 2.4x across single tenant strategy. Stable Experienced Team - Founding investment partners have worked together for 25 years. Active Management - Vertically integrated, hands-on operators in an asset class that others view as “passive.” Captive Pipeline - The Fund is expected to have access to off-market opportunities, including newly developed government and industrial build-to-suits and other investments from the firm’s complementary businesses. Secondary and Tertiary Market Operator - Our team has 8MM SF of experience across 40+ secondary and tertiary markets. BY THE NUMBERS $10 billion** in investment, acquisition, and advisory services 45+ million square feet of completed lease transactions 13.5 million SF in Development, Construction Management and Asset Management $1.2 billion active and completed principal development nationwide *Gross IRR and equity multiples for realized investments are reported net of acquisition fees, asset management fees, and entity expenses, but do not include the impact of promote. Net returns take into account promote. Past performance is not indicative of future results. **Based on total gross asset value for acquisition, development, and advisory transactions in which the firm’s principals participated, including experience at prior firms.

Starfighters Space

Starfighters Space

Innovative Technology

Starfighters Space is raising funds through Reg A+ crowdfunding with Digital Offering as the Broker-Dealer. The company privately operates a fleet of seven F-104 one- and two-seat aircraft. Starfighters Space’s supersonic flights are capable of flying at MACH 2 with air-launch rockets in development through the Starfighters STARLAUNCH program. The capabilities of Starfighters Space’s aircraft also include suborbital and orbital launches of experiments and small payloads. Rick Svetkoff founded Starfighters Space in 2022. The current crowdfunding campaign has a maximum target of $35 million. The campaign proceeds will be used for business strategy, research and development, pilot training, sales and marketing, inventory, and capital expenses.

Living City Residential

Living City Residential

Innovative Technology

LIVING CITY RESIDENTIAL invests directly in multifamily and mixed-use properties in the Western United States, with a general emphasis on supply-constrained submarkets in the Seattle, Portland, San Francisco and Los Angeles metropolitan areas. By 2Q2017, we will allocate approximately $100 million to assets with meaningful in-place income that can be augmented through superior management, cost-effective capital improvements, and in some cases construction of new or additional residences while minimizing disruption to cash flow. Over the next five years, we expect the portfolio to generate annual returns in excess of 18 percent and equity multiples in excess of 2.2x. INVESTMENT THESIS. Demographic tailwinds favor rental housing and continued urbanization. We are drawn to urban and urban-light submarkets where imbalances between the numbers of jobs and housing units persist despite recent increases in multifamily supply. Within those submarkets, we strongly prefer locations that are highly walkable or transit-oriented. Further, we prefer assets that are authentic to the genius loci – the prevailing character of a place. In this regard, our residential offerings differ from the generic apartment communities that have become the hallmarks of institutional ownership. INVESTMENT CRITERIA. We only buy properties that can produce a minimum of five percent annual yield to equity, net of debt service, as of the date of acquisition. Whenever possible, we buy properties below their replacement-costs. And we only build new or additional units when the “development spread” on those units (i.e., the difference between the pro-forma cap rate for the project and the prevailing cap rate for similar assets in the submarket) is at least two percent. TERMS AND CONDITIONS. An investment in Living City is not subject to any fees – only the actual out-of-pocket expenses incurred in buying, repositioning, and eventually selling our properties. Investors will earn a preferred return of eight percent per annum, after which the Fund Manager will earn a 20 percent carried interest. At least six percent of the Investors’ annual pref will be paid-current in the form of quarterly distributions from our cash-flowing assets.

Swordfish Energy Corporation

Swordfish Energy Corporation

Innovative Technology

Swordfish is a Horizontal Axis, Turbine that can be established as a single multi-megawatt unit or placed in arrays (multiple units) to generate multi-Gigawatts of consistent power 24 hours a day, as dependable as the tides. Swordfish Energy was established in 2020 to take advantage of the unique Tidal and River flow Horizontal Axis turbine invented by the founder. Swordfish has patents applied for, and is the ONLY generator of its kind that can generate constant and dependable Gigawatts of electrical energy whilst being completely safe for sea life and their habitat. Swordfish is a utility grade product designed for global distribution. Each individual Swordfish unit is monitored by a satellite based control system. Swordfish units have a life expectancy of 25 years. They are easier to install and easier to maintain than existing tidal generators. Due to the low profile of Swordfish, units can be installed closer to shore which allows for more viable locations. Plans are to make the output of each single or array of Swordfish generators adaptable to any geographic locations 'grid' or be delivered as an all-in-one unit. Arrays are groupings of single Swordfish units in unlimited numbers to provide utility grade service for entire communities with Gigawatts of power at competitive rates with zero impact on the environment or sea life. Single units can be near shore 'home based' tidal or river units or used for smaller establishments such as remote camps or temporary military bases, thereby eliminating costly and environmentally negative fossil fuel usage. For example; one small community of 2500 in Northern British Columbia uses 11,000,000 gallons of diesel fuel every year to power their local grid. This does not include the environmental and financial cost of delivering the fuel and maintenance costs of the generators themselves.

Berg Capital Partners

Ofer S

Team Member
Team member information

Berg Capital Partners

Innovative Technology

Berg Capital Partners is a capital markets advisory and investment firm that helps leading edge healthcare companies to source the critical investment funds required to transform their vision from concept to reality. At Berg Capital Partners, we are dedicated to collaborating closely with our healthcare clients, as we aim to establish ourselves as trusted partners throughout their capital raising journey. Our mission is to assist our clients in unlocking the full potential of their innovations, thereby making a profound impact on the well-being of countless patients worldwide. Berg Capital Partners is proud to announce our partnership with OncoHost in raising $25 million to support the commercial advancement of PROphet, a precision oncology platform revolutionizing the standard of care for non-small cell lung cancer diagnostics. OncoHost's groundbreaking approach, leveraging advanced technologies and personalized insights, aligns seamlessly with our vision for advancing breakthroughs in the oncology sector. As a forward-thinking investment firm, we recognize the tremendous clinical utility of OncoHost's PROphet platform in substantially improving patient treatment. This partnership signifies a shared commitment to pushing the boundaries of what is possible in the fight against cancer. OncoHost's dedication to tailoring patient treatments based on individual patient characteristics, coupled with Kindling Investment Partners' strategic support, positions the company for continued success and growth. We are excited about the impact this collaboration will have on advancing OncoHost's mission to transform cancer care through precision medicine. Our investment signifies not only our confidence in OncoHost's capabilities but also our belief in the potential for positive, lasting change in the lives of cancer patients. We look forward to a fruitful partnership with OncoHost and anticipate exciting developments as we collectively contribute to shaping the future of personalized cancer treatment.

Blue Ocean Capital

Blue Ocean Capital

Innovative Technology

Blue Ocean Capital LLC invests in value add multifamily 100-400 units Class B and C assets in primary markets. Blue Ocean Capital LLC invests in value add multifamily 100-400 units Class B and C assets in primary markets. We bring these offerings to our investors. Our investors are doctors, nurses, healthcare workers, and other busy professionals. Our investors like the tax-efficient passive income. Please sign up on our investor portal. www.bluoceacap.com. We are dedicated to creating passive income streams through apartment investing and building communities. The key to creating any change is a change in mindset to achieve success and grow in life. An entrepreneurial mindset is something that can be created. The ultimate goal is having access to a fulfilling happy life. Join us in this Journey!!

We use cookies on this site to enhance your user experience and analyze site traffic. By clicking "Accept", you consent to our use of cookies. Read our cookie policy